期刊文献+

非典型抗精神病药所致食欲增加的生物学机制研究进展 被引量:2

原文传递
导出
摘要 精神分裂症是一种全球性、易复发性、难治愈性精神疾病,发病原因迄今仍未完全阐明,我国1998年流行病学调查显示分裂症患病率为6.55%,国际研究显示近25年来患病率没有减少Ⅲ。目前多个国家的治疗指南均推荐使用非典型抗精神病药作为精神分裂症患者的首选用药。
作者 禚传君
机构地区 天津市安宁医院
出处 《中华行为医学与脑科学杂志》 CAS CSCD 北大核心 2013年第10期957-958,共2页 Chinese Journal of Behavioral Medicine and Brain Science
基金 中国博士后基金资助项目(2012M520585) 国家自然科学基金资助项目(81271514)
  • 相关文献

参考文献31

  • 1陈昌惠,沈渔笛,张维熙,李淑然,黄悦勤,王金荣,王德平,涂建,宁佐喜,付力牧,纪丽萍,刘志广,吴化民,罗开林,翟书涛,严和,孟国荣.中国七个地区精神分裂症流行病学调查[J].中华精神科杂志,1998,31(2):72-74. 被引量:173
  • 2Shivashankar S,Telfer S,Arunagiriraj J,et al.Has the prevalence,clinical presentation and social functioning of schizophrenia changed over the last 25years? Nithsdale schizophrenia survey revisited.Schizophr Res,2013,146:349-356.
  • 3Mitchell AJ,Vancampfort D,Sweers K,et al.Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders--a systematic review and meta-analysis.Schizophr Bull,2013,39:306-318.
  • 4张文跃,祁小飞,杨忠,王梅芬,顾凤华,宣春明,韩晓东.G蛋白β3亚单位基因多态性与抗精神病药源性肥胖的相关性[J].中华行为医学与脑科学杂志,2011,20(12):1101-1103. 被引量:1
  • 5De Hert M,Vancampfort D,Correll C U,et al.Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia:systematic evaluation.Br J Psychiatry,2011,199:99-105.
  • 6Vancampfort D,Vansteelandt K,Correll CU,et al.Metabolic syndrome and metabolic abnormalities in bipolar disorder:a meta-analysis of prevalence rates and moderators.Am J Psychiatry,2013,170:265-274.
  • 7Basson BR,Kinon B J,Taylor CC,et al.Factors influencing acute weight change in patients with schizophrenia treated with olanzapine,haloperidol,or risperidone.J Clin Psychiatry,2001,62:231-238.
  • 8Kinon B J,Kaiser C J,Ahmed S,et al.Association between early and rapid weight gain and change in weight over one year of olanzapine therapy in patients with schizophrenia and related disorders.J Clin Psychopharmacol,2005,25:255-258.
  • 9Gothelf D,Falk B,Singer P,et al.Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine.Am J Psychiatry,2002,159:1055-1057.
  • 10Theisen FM,Linden A,K(o)nig IR,et al.Spectrum of binge eating symptomatology in patients treated with clozapine and olanzapine.J Neural Transm,2003,110:111-121.

二级参考文献31

  • 1施辉,徐晶宇,赵汉清,纪菊英,徐乐平,朱静,孙剑.2132例首次接受治疗精神分裂症患者糖尿病患病率调查[J].中国行为医学科学,2007,16(5):438-438. 被引量:6
  • 2中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5230
  • 3Baptista T,Kin NM,Beaulieu S,et al.Obesity and related metabolic abnormalities during antipsychotic drug administration:mechanisms,management and research perspectives.Pharmacopsychiatry,2002,35:205-219.
  • 4Sifftert W,Forster P,Jockel KH,et al.Worldwide ethnic distribution of G protein beta3 subunit 825T allele and its association with obesity in Caucasian,Chinese,and Black African individuals.J Am Soc Nephrol,1999,10:1921-1930.
  • 5Bishop JR,Ellingrod VL,Moline J,et al.Pilot study of G-protein beta3 subunit gene (C825T) polymorphism and clinical response to olanzapine or olanzapine-related weight gain in persons with schizophrenia.Med Sci Monit,2006,12:47-50.
  • 6Wang YC,Bai YM,Chen JY,et al.C825T polymorphism in human G protein beta3 subunit gene is associated with long-term clozapine treatment-induced body weight change in Chinese population.Pharmacogenet Genomics,2005,15:743-748.
  • 7Ujike H,Nomura A,Morita Yet al.Multiple genetic factors in olanzapine-induced weight gain in schizophrenia patients:a cohort study.J Clin Psychiatry,2008,69:1416-1422.
  • 8Park YM,Chung YC,Lee SH,et al.G-protein beta3 subunit gene 825C/T polymorphism is not associated with olanzapine-induced weight gain in Korean schizophrenic patients.Psychiatry Invest,2009,6:39-43.
  • 9Ryden M,Faulds G,Hoffstedt J,et al.Effect of the (C825T) G beta (3) polymorphism on adrenoceptor-mediated lipolysis in human fat cell.Diabetes,2002,51:1601-1608.
  • 10Nasrallah H.A review of the effect of atypical antipsychotics on weight.Psychoneuroendocrinology,2003,28 (suppl 1):83-96.

共引文献186

同被引文献40

  • 1刘福权,陈大春,李瑛,高淑英,张国玲,柏林,柴佳宝,王阳,宋佳起,赵青,倪海清.精神分裂症共病超重或肥胖的临床特征及风险因素[J].中国健康心理学杂志,2020,0(3):328-332. 被引量:8
  • 2Dockray GJ. Gastrointestinal hormones and the dialogue between gut and brain[J] J Physiol,2014,592(Ptl4) :2927-2941.
  • 3Mietlicki-Baase EG, Ortinski PI, Rupprecht LE, et at. The food intake- suppressive effects of glucagon-like peptide-I receptor signaling in the ventral tegmental area are mediated by AMPA/kainate receptors [ J]. Am J Physiol Endocrino| Metab,2013,305( 11 ) :E1367-1574.
  • 4Engel JA,Jerlhag E.Alcohol: mechanisms along the mesolimbic dopa- mine system[J]. Prog Brain Res,2014,211 ( 1 ) :201-233.
  • 5Kedia G, Mussweiler T, Linden DE. Brain mechanisms of social com- parison and their influence on the reward system [ J ]. Neuroreport, 2014,25(16) : 1255-1265.
  • 6Olds J, Milner P.Positive reinforcement produced by electrical stimula- tion of septal area and other regions of rat brain [J]. J Comp PhysiolPsychol, 1954,47(6) :419-427.
  • 7Radovanovic CA, Santos LA, Carvalho MD, et al. Arterial Hyperten- sion and other risk factors associated with cardiovascular diseases a- mong adults [J]. Rev Lat Am Enfermagem,2014,22{4) :547-553.
  • 8Bidgoli SA ,Jahari N, Zavarhei MD. Prostate-specific antigen levels in relation to background factors: are there links to endocrine disrupting chemicals and AhR expression? [ J ] .Asian P ac J Cancer Prey, 2014, 15(15) :6121-6125.
  • 9Mear Y, Blanchard MP, Defilles C, et al.Ghrelin receptor (GHS-Rla) and its constitutive activity in somatotroph adenomas: a new co-targe- ting therapy using GHS-Rla inverse agonists and somatostatin analogs [J]. J Clin Endocrinol Metah.2014 [Elub ahead of print].
  • 10Harris G, Shen Y, Ha H, et al. Dissecting the signaling mechanisms underlying recognition and preference of food odors [ J ]. J Neuresci, 2014,34(28) :9389-9403.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部